CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade TFF Pharmaceuticals, Inc. - TFFP CFD

1.83
5.78%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.73
Open 1.73
1-Year Change 343.59%
Day's Range 1.73 - 1.84
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 1.74 0.08 4.82% 1.66 1.74 1.64
Jul 24, 2024 1.68 0.02 1.20% 1.66 1.70 1.66
Jul 23, 2024 1.72 0.03 1.78% 1.69 1.81 1.69
Jul 22, 2024 1.79 0.04 2.29% 1.75 1.79 1.66
Jul 19, 2024 1.88 0.03 1.62% 1.85 1.88 1.78
Jul 18, 2024 1.83 -0.10 -5.18% 1.93 1.94 1.73
Jul 17, 2024 1.93 -0.04 -2.03% 1.97 2.00 1.88
Jul 16, 2024 1.95 0.01 0.52% 1.94 2.06 1.86
Jul 15, 2024 1.93 -0.10 -4.93% 2.03 2.03 1.86
Jul 12, 2024 1.96 -0.04 -2.00% 2.00 2.00 1.87
Jul 11, 2024 2.02 0.02 1.00% 2.00 2.03 1.91
Jul 10, 2024 1.99 0.00 0.00% 1.99 2.09 1.98
Jul 9, 2024 1.89 0.02 1.07% 1.87 2.06 1.84
Jul 8, 2024 1.86 0.12 6.90% 1.74 1.89 1.74
Jul 5, 2024 1.73 -0.06 -3.35% 1.79 1.79 1.66
Jul 3, 2024 1.73 0.00 0.00% 1.73 1.83 1.71
Jul 2, 2024 1.74 -0.02 -1.14% 1.76 1.76 1.64
Jul 1, 2024 1.76 0.11 6.67% 1.65 1.90 1.64
Jun 28, 2024 1.58 -0.04 -2.47% 1.62 1.63 1.58
Jun 27, 2024 1.55 -0.19 -10.92% 1.74 1.77 1.53

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

TFF Pharmaceuticals, Inc. Company profile

About TFF Pharmaceuticals Inc

TFF Pharmaceuticals, Inc. is an early stage biopharmaceutical company. The Company is focused on developing and commercializing drug products based on its Thin Film Freezing (TFF) technology platform. Its TFF platform is designed to enable solubility of poorly water-soluble drugs. Its drug candidates include TFF Voriconazole Inhalation Powder (VIP), TFF Tacrolimus Inhalation Powder (TIP) and Triple Combination. It is developing TFF VIP to treat invasive pulmonary aspergillosis (IPA), a severe fungal pulmonary disease. TFF VIP is being developed as an inhaled dry powder drug. It is developing TFF TIP, a dry powder version of Tacrolimus, an immunosuppressive drug used in transplant medicine. It is developing Triple Combination, a dry powder drug combination to treat chronic obstructive pulmonary disease (COPD) and asthma. Its other dry powder products include Inhaled SARS-CoV2 Monoclonal Antibody, Niclosamide Inhalation Powder, Cannabidiol (CBD) and Vaccines.

Financial summary

BRIEF: For the nine months ended 30 September 2021, TFF Pharmaceuticals Inc revenues increased from $0K to $76K. Net loss increased 66% to $21M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $2.8M to $14.1M (expense), Stock-based Compensation in SGA increase of 98% to $2.4M (expense).

Industry: Biotechnology & Medical Research (NEC)

2600 Via Fortuna Ste 360
AUSTIN
TEXAS 78746-7983
US

People also watch

XRP/USD

0.61 Price
+1.640% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,928.50 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,281.07 Price
+4.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading